Simplex Trading’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-212
Closed -$76 9233
2025
Q3
$0 Sell
212
-400
-65% -$152 ﹤0.01% 9474
2025
Q2
$0 Sell
612
-100
-14% -$30 ﹤0.01% 9139
2025
Q1
$0 Sell
712
-200
-22% -$63 ﹤0.01% 8997
2024
Q4
$0 Sell
912
-100
-10% -$37 ﹤0.01% 9015
2024
Q3
$0 Sell
1,012
-1,000
-50% -$401 ﹤0.01% 8962
2024
Q2
$0 Buy
+2,012
New +$1K ﹤0.01% 9244
2023
Q1
Sell
-1,000
Closed -$375 9502
2022
Q4
$0 Hold
1,000
﹤0.01% 9717
2022
Q3
$0 Hold
1,000
﹤0.01% 10350
2022
Q2
$0 Hold
1,000
﹤0.01% 10438
2022
Q1
$0 Hold
1,000
﹤0.01% 10843
2021
Q4
$0 Sell
1,000
-25,547
-96% -$34.3K ﹤0.01% 10889
2021
Q3
$45K Buy
26,547
+22,844
+617% +$36.9K ﹤0.01% 7626
2021
Q2
$6K Sell
3,703
-83,113
-96% -$127K ﹤0.01% 9373
2021
Q1
$155K Buy
86,816
+66,397
+325% +$121K ﹤0.01% 5129
2020
Q4
$31K Buy
20,419
+8,377
+70% +$12.4K ﹤0.01% 6628
2020
Q3
$12K Buy
+12,042
New +$12.2K ﹤0.01% 6699
2020
Q1
Sell
-100
Closed 7881
2019
Q4
$0 Buy
+100
New +$82 ﹤0.01% 7576
2019
Q3
Sell
-9,193
Closed -$11.1K 7524
2019
Q2
$15K Buy
9,193
+4,265
+87% +$6.03K ﹤0.01% 5837
2019
Q1
$10K Buy
4,928
+4,728
+2,364% +$10.7K ﹤0.01% 6154
2018
Q4
$0 Buy
+200
New +$1.02K ﹤0.01% 7360

Other funds holding IGC

Simplex Trading's IGC Position: Q4 2025 in Review

Simplex Trading sold out of IGC Pharma (IGC) in Q4 2025, closing a stake of 212 shares — an estimated $76 sold.

Simplex Trading first reported a position in IGC in Q4 2018 and held it in 20 quarters. The position peaked at $155K in Q1 2021. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2025.

  • Simplex Trading reported no remaining IGC Pharma position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 212 IGC Pharma shares in Q4 2025, an estimated $76.
  • Simplex Trading first reported a position in IGC Pharma in Q4 2018 and held it in 20 quarters.
  • Simplex Trading's IGC Pharma position peaked at $155K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.